» Articles » PMID: 34676178

Any Correlation Between Prostate Volume and Incidence of Prostate Cancer: A Review of Reported Data for the Last Thirty Years

Overview
Journal Res Rep Urol
Publisher Dove Medical Press
Specialty Urology
Date 2021 Oct 22
PMID 34676178
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Prostate cancer (PCa) is the most common non-skin cancer in men worldwide and more than 80% of men with PCa also have histo-anatomical findings of benign prostate hyperplasia (BPH). It is well documented that BPH develops in the transition zone (TZ), whereas 80-85% of PCa originates in the peripheral zone (PZ) of the prostate. Possible causal links between both disease entities are controversially discussed in the current literature. Some studies have reported that larger prostates have a decreased incidence of PCa compared to smaller prostates. The purpose of this systematic review is to comprehensively summarize studies analyzing any association between prostate gland volume and incidence of PCa.

Methods: A thorough literature review was performed between 01.01.1990 through 02.28.2020 using PubMed and applying the "PRISMA" guidelines. Inclusion and exclusion criteria were defined.

Results: Our systematic review found 41 articles reporting an inverse (negative) relationship between prostate gland volume and incidence of prostate cancer. Sample sizes ranged from 114 to 6692 patients in these single institutional and multi-institutional studies. Thirty-nine (95%) of the 41 articles showed a statistically significant inverse relationship. In our search, no study was found showing a positive correlation between BPH size and the incidence of PCa.

Conclusion: To our knowledge, this is the first systematic review on the important clinical question of interaction between prostate size and the incidence of PCa. The results are demonstrating an inverse relationship, and therefore reveal strong evidence that large prostates may be protective of PCa when compared to smaller prostates.

Citing Articles

Negative magnetic resonance imaging cannot be used to omit an initial prostate biopsy - An ambispective study.

Arulraj K, Sharma S, Das C, Seth A, Kumar R Prostate Int. 2025; 12(3):128-133.

PMID: 39816937 PMC: 11733748. DOI: 10.1016/j.prnil.2024.03.005.


The Correlation Between Body Mass Index and Prostate Volume: A Retrospective Analysis of Pre and Postoperative Measurements in Prostate Cancer Patients.

Barone B, Amicuzi U, Massanova M, Napolitano L, Reccia P, Mirto B Prostate. 2024; 85(5):433-442.

PMID: 39716024 PMC: 11848972. DOI: 10.1002/pros.24845.


Polygenic anti-cancer activity of in prostate cancer induced animal model.

Alabi G, Elekofehinti O, Sanni D, Ashaolu J, Oluwatuyi A Toxicol Rep. 2024; 13:101774.

PMID: 39554609 PMC: 11567122. DOI: 10.1016/j.toxrep.2024.101774.


Single-cell analysis reveals alternations between the aged and young mice prostates.

Li Y, Ding Y, Hou Y, Liu L, Liu Z, Yao Z Biomark Res. 2024; 12(1):117.

PMID: 39385256 PMC: 11462726. DOI: 10.1186/s40364-024-00666-x.


Computerized metric assessment of glandular tissue volume within the peripheral zone of the prostate using combined magnetic resonance imaging and histopathology: Possible pathophysiological implications on prostate cancer development.

Wolpert J, Presson C, Kimball N, Lin B, Brandi L, Helo N Investig Clin Urol. 2024; 65(4):334-341.

PMID: 38978213 PMC: 11231661. DOI: 10.4111/icu.20240040.


References
1.
Inahara M, Suzuki H, Kojima S, Komiya A, Fukasawa S, Imamoto T . Improved prostate cancer detection using systematic 14-core biopsy for large prostate glands with normal digital rectal examination findings. Urology. 2006; 68(4):815-9. DOI: 10.1016/j.urology.2006.05.010. View

2.
Kobayashi T, Mitsumori K, Kawahara T, Nishizawa K, Ogura K, Ide Y . Prostate gland volume is a strong predictor of biopsy results in men 70 years or older with prostate-specific antigen levels of 2.0-10.0 ng/mL. Int J Urol. 2005; 12(11):969-75. DOI: 10.1111/j.1442-2042.2005.01189.x. View

3.
Guess H . Benign prostatic hyperplasia and prostate cancer. Epidemiol Rev. 2001; 23(1):152-8. DOI: 10.1093/oxfordjournals.epirev.a000782. View

4.
Alberts A, Schoots I, Roobol M . Prostate-specific antigen-based prostate cancer screening: Past and future. Int J Urol. 2015; 22(6):524-32. DOI: 10.1111/iju.12750. View

5.
Liu F, Hua K, Lin J, Pang S, Yu H . Prostate resected weight and postoperative prostate cancer incidence after transurethral resection of the prostate: A population-based study. Medicine (Baltimore). 2019; 98(3):e13897. PMC: 6370121. DOI: 10.1097/MD.0000000000013897. View